Phase I clinical studies with cytotoxic drugs: pharmacokinetic and pharmacodynamic considerations

Br J Cancer. 1990 Feb;61(2):189-91. doi: 10.1038/bjc.1990.35.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / pharmacokinetics*
  • Antineoplastic Agents / pharmacology
  • Drug Evaluation
  • Drug Screening Assays, Antitumor
  • Humans
  • Methods
  • Mice

Substances

  • Antineoplastic Agents